Please consider participating in our observational research aimed at studying how the human immune system fights cancer. The immune system protects us by recognizing and eliminating threats, but cancer cells are skilled at evading the body's natural immune response. Fortunately, the human immune system is resilient and constantly adapting to better locate and attack threats such as cancer cells. With this research, we hope to advance our understanding of how the immune system fights cancer and enable new treatments along the way.Participate in our study
This research aims to study the effective anti-tumor immune responses of patients like you. Your blood can help us understand how the immune system adapts to fight cancer.
The study involves a phone interview with the research professionals at Atreca to assess whether the study is a good match for you. If you qualify, we will send a technician to you to collect a blood sample.
Atreca's clinical research professionals are here to talk to you. If you are interested in participating in our research study or would simply like to find out more, please fill out the screening questionnaire below.
Atreca, Inc. is a biotechnology company founded on the invention of a novel technology by Stanford scientists Bill Robinson, MD, PhD and Yann Chong Tan, PhD. Atreca has developed this technology to help identify and analyze proteins called antibodies that are made by the immune system. Some anti-tumor antibodies will stick to the surface of tumor cells and alert the rest of your immune system to attack those harmful cells. Atreca’s goal is to identify those well-adapted antibodies so that we can both advance our knowledge of cancer as a disease, and seek new treatments for future patients.